Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus

Journal of Dermatological Science

Volumn 75, Issue 3, 2014, Pages 167-172

  Eirís, Noemí ^a   González Lara, Leire ^a   Santos Juanes, Jorge ^a   Queiro, Rubén ^a   Coto, Eliecer ^a   Coto Segura, Pablo ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Genetics; Psoriasis; Psoriatic arthritis; Type 2 diabetes

Indexed keywords

CYTOKINE; INTERLEUKIN 12P40; INTERLEUKIN 23P19; INTERLEUKIN 23R; UNCLASSIFIED DRUG; IL23A PROTEIN, HUMAN; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERTENSION; IL12B GENE; IL23A GENE; IL23R GENE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENE FREQUENCY; GENETICS; GENOTYPE; INTRON; MIDDLE AGED; RISK FACTOR; SPAIN;

ADULT; ALLELES; ARTHRITIS, PSORIATIC; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23 SUBUNIT P19; INTRONS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RECEPTORS, INTERLEUKIN; RISK FACTORS; SPAIN;

EID: 84905056089     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.05.010     Document Type: Article

References (31)

1. Hüffmeier U., Lascorz J., Böhm B., Lohmann J., Wendler J., Mössner R., et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009, 129:355-358.
2. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80:273-290.
3. Capon F., Di Meglio P., Szaub J., Prescott N.J., Dunster C., Baumber L., et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007, 122:201-206.
4. Nair R., Ruether A., Stuart P., Jenisch S. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008, 128:1653-1661.
5. Zhu K.-J., Zhu C.-Y., Shi G., Fan Y.-M. Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis. Inflamm Res 2012, 61:1149-1154.
6. Zhu K.-J., Zhu C.-Y., Shi G., Fan Y.-M. Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. Rheumatol Int 2013, 33:1785-1790.
7. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002, 30:161-166.
8. Oka A., Mabuchi T., Ikeda S., Terui T., Haida Y., Ozawa A., et al. IL12B and IL23R gene SNPs in Japanese psoriasis. Immunogenetics 2013, 65:823-828.
9. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009, 41:199-204.
10. Chen H., Poon A., Yeung C., Helms C., Pons J., Bowcock A.M., et al. A genetic risk score combining ten psoriasis risk loci improves disease prediction. PloS one 2011, 6:e19454.
11. Boehncke S., Thaçi D., Beschmann H., Ludwig R.J., Ackermann H., Badenhoop K., et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007, 157:1249-1251.
12. Sommer D.M., Jenisch S., Suchan M., Christophers E., Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatolo Res 2006, 298:321-328.
13. Armstrong A.W., Schupp C., Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatol 2012, 225:121-126.
14. Jacobi A., Kupke C., Behzad M., Hertl M. Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study. Int J Dermatol 2013, 52:1081-1087.
15. Yeung H., Takeshita J., Mehta N.N., Kimmel S.E., Ogdie A., Margolis D.J., et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013, 149:1173-1179.
16. Armstrong A.W., Harskamp C.T., Armstrong E.J. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013, 68:654-662.
17. Boehncke W.H., Boehncke S., Tobin A.M., Kirby B. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011, 20:303-307.
18. Su Y.S., Yu H.S., Li W.C., Ko Y.C., Chen G.S., Wu C.S., et al. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy. J Eur Acad Dermatol Venereol 2013, 27:876-883.
19. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753.
20. Coto-Segura P., González-Lara L., Eiris N., Santos-Juanes J., Queiro R., Coto E. Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with Psoriasis. Br J Dermatol 2014, [in press]. 10.1111/bjd.13000.
21. Lu Y., Chen H., Nikamo P., Qi Low H., Helms C., Seielstad M., et al. Association of cardiovascular and metabolic disease genes with psoriasis. J Invest Dermatol 2013, 133:836-839.
22. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673.
23. Eiris N., Santos-Juanes J., Coto-Segura P., Gómez J., Alvarez V., Morales B., et al. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes. Cytokine 2012, 60:27-29.
24. Boca A.N., Talamonti M., Galluzzo M., Botti E., Vesa S.C., Chimenti S., et al. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis. Immunol Lett 2013, 156:127-131.
25. Smith R.L.L., Warren R.B., Eyre S., Ho P., Ke X., Young H.S., et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol 2008, 128:1325-1327.
26. Filer C., Ho P., Smith R.L., Griffiths C., Young H.S., Worthington J., et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 2008, 58:3705-3708.
27. Kwatra S.G., Dabade T.S., Gustafson C.J., Feldman R. JAK inhibitors in psoriasis: a promising new treatment modality. Drugs Dermatol 2012, 11:913-918.
28. Costa V.S., Santos S., Fukui R.T., Mattana T.C.C., Matioli S.R., Silva M.E.R. Protective effect of interleukin-23A (IL23A) haplotype variants on type 1A diabetes mellitus in a Brazilian population. Cytokine 2013, 62:327-333.
29. Bowes J., Orozco G., Flynn E., Ho P., Brier R., Marzo-Ortega H., et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 2011, 70:1641-1644.
30. Langan S.M., Seminara N.M., Shin D.B., Troxel A.B., Kimmel S.E., Mehta N.N., et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012, 132:556-562.
31. Coto-Segura P., Eiris-Salvado N., González-Lara L., Queiro-Silva R., Martinez-Camblor P., Maldonado-Seral C., et al. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 2013, 169:783-793.